Evidence Supports Content Validity of Patient-Reported Outcome Measures in Inflammatory Myositis
Researchers investigated the content validity of patient-reported outcome measures in patients with idiopathic inflammatory myopathies.
Dermatomyositis
Cancer Screening Strategies in Rheumatic Diseases: Expert Perspectives
Experts highlight the need for cancer screening strategies in patients with rheumatic diseases.
Evaluating the Correlation Between the Validated and a Modified Disease Activity Score in Juvenile Dermatomyositis
Researchers determined whether a modified disease activity score (DAS) correlated with the validated DAS in patients with juvenile dermatomyositis.
Juvenile Dermatomyositis Associated With Risk for Delayed Pubertal Development
Researchers studied growth and puberty in a multinational prospective cohort of children with juvenile dermatomyositis.
Endothelial Biomarker Levels Elevated and Linked to Extramuscular Activity in Juvenile Dermatomyositis
Researchers analyzed endothelial biomarker levels in the peripheral blood of patients with juvenile dermatomyositis and their association with disease assessments.
Discordance Between Patient or Family and Physician Assessments Common in Juvenile Dermatomyositis
Researchers measured discordance between patient or family and physician global activity scores in juvenile dermatomyositis, and determined factors associated with discordance.
Prominent Muscle Involvement in Dermatomyositis With and Without Anti-Mi2 Autoantibodies
Muscle disease is more prominent among patients with dermatomyositis and anti-Mi2 autoantibodies compared with in those who have anti-Mi2-negative dermatomyositis.
Ultraviolet Radiation Exposure Associated With Dermatomyositis Diagnosis
Researchers studied the role of individual determinants of ultraviolet radiation exposure prior to dermatomyositis diagnosis.
Predictors Identified for Myositis-Related Interstitial Lung Disease Mortality
Researchers identified independent predictors of short-term dermatomyositis- or polymyositis-related interstitial lung disease mortality.
CDASI Predicts Cutaneous Dermatomyositis Disease Course and Progression
Tools that can effectively predict course and progression of dermatomyositis can help to identify optimal treatment and ultimately improve quality of life for patients with this rare and debilitating autoimmune disease.
-
Loading...
-
Loading...
Next post in Inflammatory Myopathy
